Baigent C, Blackwell L, Collins R, et al. Aspirin in the primary
and secondary prevention of vascular disease: collaborative
meta-analysis of individual participant data from randomised
Lancet 2009; 373:1849-60.
De Berardis G, Sacco M, Strippoli GF, et al. Aspirin for primary
prevention of cardiovascular events in people with diabetes:
meta-analysis of randomised controlled trials.
BMJ 2009; 339:b4531.
Aspirin for primary prevention of cardiovascular disease?
Drug and Therapeutics Bulletin 2009; 47:122-5.
To continue reading this article, you must login
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.